Skip to main content

Neuralink competitor Synchron to ramp up brain implant production with equity stake in manufacturer

Synchron is readying for commercial demand as the company inches closer to bringing its device to market.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.